Orlistat , >97.0%(HPLC) , 96829-58-2
                            Synonym(s):
(−)-Tetrahydrolipstatin;N-Formyl-L-leucine (1S)-1-[[(2S,3S)-3-hexyl-4-oxo-2-oxetanyl]methyl]dodecyl ester;Orlistat;Ro-18-0647
                            
                        
                CAS NO.:96829-58-2
Empirical Formula: C29H53NO5
Molecular Weight: 495.73
MDL number: MFCD05662360
EINECS: 639-755-1
| Pack Size | Price | Stock | Quantity | 
| 100MG | RMB31.20 | In Stock | 
                                                 | 
                                        
| 250MG | RMB39.20 | In Stock | 
                                                 | 
                                        
| 1G | RMB56.80 | In Stock | 
                                                 | 
                                        
| 5G | RMB100.00 | In Stock | 
                                                 | 
                                        
| 25G | RMB476.00 | In Stock | 
                                                 | 
                                        
| 100G | RMB1268.00 | In Stock | 
                                                 | 
                                        
| others | Enquire | 
PRODUCT Properties
| Melting point: | <50 °C | 
                                    
| Boiling point: | 615.9±30.0 °C(Predicted) | 
                                    
| alpha | D20 -32.0° (c = 1 in chloroform) | 
                                    
| Density | 0.976±0.06 g/cm3(Predicted) | 
                                    
| storage temp. | 2-8°C | 
                                    
| solubility | DMSO: 19 mg/mL | 
                                    
| form | solid | 
                                    
| pka | 14.59±0.23(Predicted) | 
                                    
| color | white | 
                                    
| biological source | synthetic (organic) | 
                                    
| Merck | 14,6869 | 
                                    
| Stability: | Stable for 1 year from date of purchase as supplied. Solutions in DMSO or ethanol may be stored at -20° for up to 1 week. | 
                                    
| InChIKey | AHLBNYSZXLDEJQ-FWEHEUNISA-N | 
                                    
| SMILES | C(O[C@H](C[C@H]1[C@H](CCCCCC)C(=O)O1)CCCCCCCCCCC)(=O)[C@H](CC(C)C)NC=O | 
                                    
| CAS DataBase Reference | 96829-58-2(CAS DataBase Reference) | 
                                    
Description and Uses
Orlistat is a digestive lipase inhibitor. It inhibits diacylglycerol lipase α (DAGLα), DAGLβ, α/β-hydrolase domain-containing protein 12 (ABHD12), ABHD16A, and platelet-activating factor acetylhydrolase (PAF-AH; IC50s = 0.06, 0.1, 0.08, 0.03, and 0.05 μM, respectively), as well as pancreatic lipase and hormone-sensitive lipase (IC50s = 0.65 and 2.1 μg/ml, respectively) but does not inhibit fatty acid amide hydrolase (FAAH) or KIAA1363 (IC50s = >100 μM for both). Orlistat decreases ionomycin-induced production of the endocannabinoid 2-arachidonoyl glycerol (2-AG) in N18TG2 murine neuroblastoma cells when used at a concentration of 1 μM. It also inhibits fatty acid synthase (FASN; Kiapp = ~0.1 μM for the human enzyme) and the proliferation of PC3 prostate cancer cells in a concentration-dependent manner. Orlistat (10 mg/kg) decreases serum cholesterol levels and total body weight in a mouse model of obesity induced by a high-fat diet. Formulations containing orlistat have been used in the treatment of adult obesity.
Orlistat is an antiobesity agent. Orlistat is an pancreatic lipase inhibitor.
Safety
| Symbol(GHS) | ![]() GHS07  | 
                                    
| Signal word | Warning | 
| Hazard statements | H302-H412 | 
| Precautionary statements | P273 | 
| WGK Germany | 3 | 
| RTECS | OH3167600 | 
| HS Code | 29322090 | 
| Hazardous Substances Data | 96829-58-2(Hazardous Substances Data) | 




